Nipro Corporation
Nipro Corporation (NPRRF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nprrf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Nipro CorporationYou NPRRF | $1.6B | 20.62x | -43.3% | $82.80 |
 Biotest AG BIESF | $1.6B | 41.48x | +14.1% | $0.71 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +27.2% | $3.55 |
 CompuGroup Medical SE & Co. KGaA CMPUY | $1.2B | 33.34x | -8.3% | $0.67 |
 CompuGroup Medical SE & Co. KGaA CMPVF | $1.7B | 52.49x | +44.4% | $0.55 |
 Drägerwerk AG & Co. KGaA DGWPF | $1.4B | 8.23x | -77.4% | $7.44 |
 Drägerwerk AG & Co. KGaA DWRKF | $1.8B | N/A | — | — |
Industry Average 5 peers with valid PE | — | 36.36x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Nipro Corporation (NPRRF) measures how much investors pay for each dollar of the company's trailing earnings. NPRRF's current PE ratio of 20.62x is calculated by dividing its stock price of $9.69 by its TTM earnings per share of $82.80.
Frequently asked questions
NPRRF pe ratio · 6 questionsNPRRF's current PE ratio is 20.62x as of 2026-06-09, based on a stock price of $9.69 and TTM EPS of $82.80. Data sourced from Financial Modeling Prep via NPRRF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nipro Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09